Studies have indicated that its serum level is decreased in patients with obesity and type 2 diabetes, and it is also considered as an anti-inflammatory cytokine, which can promote IR by reducing inflammatory response and regulating insulin signal transduction [29]. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.